Pawtucket / Philadelphia / Arlington / Seattle / Boston / Baltimore / Nairobi / Washington / DC / Providence / London / /
Company
Stone AB / HIV Prevention Trials Network / Fleming / ReProtect / Abt Associates / New England Journal / /
Country
Thailand / Malawi / India / Cameroon / Zimbabwe / United States / /
Currency
USD / /
Event
FDA Phase / M&A / /
Facility
Infants Hospital / Memorial Hospital / University of Washington / University of North Carolina / University of California / The Miriam Hospital / National Institute of Allergy / New York Blood Center / Howard Brown Health Center / Brown University / Chapel Hill / University of Pennsylvania Press / Fred Hutchinson Cancer Research Center / New York University Medical Center / University of Pennsylvania / /
IndustryTerm
university media / HIV Prevention / local public media / vaginal microbicide products / AIDS Prevention / focus / microbicide product / participants recontrol / vaginal products / focus groups / uniform protocol / study protocol / vaginal microbicide product / data management / dozen microbicide products / /
University of Washington / Denver Public Health Department / U.S. government / Center for AIDS Prevention Studies / office of Protection / National Institute of Allergy and Infectious Diseases / Women and Infants Hospital / San Francisco Department of Public Health / University of California at San Francisco / Alliance for Microbicide Development / Miriam Hospital / Massachusetts Department of Public Health / New York Blood Center / Food and Drug Administration / Brown University / University of Pennsylvania / Memorial Hospital / University of Pennsylvania Press / International Center for Research / Department of Nutrition / School of Public Health / Brown University School of Medicine / Howard Brown Health Center / American Medical Association / Carolina Population Center / University of North Carolina / Chapel Hill / New York University Medical Center / Fenway Community Health Center / /
Person
Cliff Kelly / Michael Gross / Margaret E. Bentley / Fran Bettencourt / Ward Cates / Jr. / Ann Koonce / Sexually Transmitted / Lynda Emel / Susan Kelly / Rochelle Rosen / Amy Cooper / Frances Dancy / Andrew Fullem / Kathleen M. Morrow / Kenneth H. Mayer / Thomas Moench / Scott D. Horton / Julie Welch / Leslie Hjeldness / Kevin Whaley / Kenrad Nelson / Zeda Rosenberg / David Celentano / Margaret A. Chesney / Never / /
Position
associate chair and associate professor / professor / representative / model for future Phase I microbicide trials / scientific director / BufferGel Investigator / data operations manager / director / HIV/AIDS Surveillance / assistant professor / /
Product
BufferGel / Phase I microbicide / vaginal / /
ProvinceOrState
Rhode Island / California / North Carolina / /
PublishedMedium
American Journal of Public Health / New England Journal of Medicine / Clinical Infectious Diseases / Journal of the American Medical Association / /
Technology
uniform protocol / study protocol / Adherence The protocol / Cable TV / artificial intelligence / /
Acceptability of a Novel Vaginal Microbicide During A Safety Trial Among Low-Risk Women By Margaret E. Bentley, Kathleen M. Morrow, Andrew Fullem, Margaret A. Chesney, Scott D. Horton, Zeda Rosenberg and Kenneth H. Mayer